ADAPTIMMUNE THERAPEUTICS PLC Share-based Payment Arrangement, Exercise of Option, Tax Benefit
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Share-based Payment Arrangement, Exercise of Option, Tax Benefit of $617.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Additional Disclosure
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions · last filed 2025-03-24
- ADAPTIMMUNE THERAPEUTICS PLC share-based payment arrangement, exercise of option, tax benefit for fiscal 2024 was $617.00K, a 14.05% increase from fiscal 2023.
- ADAPTIMMUNE THERAPEUTICS PLC share-based payment arrangement, exercise of option, tax benefit for fiscal 2023 was $541.00K, a 10.86% increase from fiscal 2022.
- ADAPTIMMUNE THERAPEUTICS PLC share-based payment arrangement, exercise of option, tax benefit for fiscal 2022 was $488.00K, a 43.39% decline from fiscal 2021.
- ADAPTIMMUNE THERAPEUTICS PLC share-based payment arrangement, exercise of option, tax benefit for fiscal 2021 was $862.00K, a 31.86% decline from fiscal 2020.
| Period end | Share-based Payment Arrangement, Exercise of Option, Tax Benefit 6 month | Share-based Payment Arrangement, Exercise of Option, Tax Benefit 12 month |
|---|---|---|
| 2024-12-31 | $617.00K 10-K · filed 2025-03-24 | |
| 2023-12-31 | $541.00K 10-K · filed 2025-03-24 | |
| 2022-12-31 | $488.00K 10-K · filed 2025-03-24 | |
| 2021-12-31 | $862.00K 10-K · filed 2024-03-06 | |
| 2020-12-31 | $1.26M 10-K · filed 2023-03-06 | |
| 2019-12-31 | $1.49M 10-K · filed 2022-03-14 | |
| 2018-12-31 | $1.32M 10-K · filed 2021-02-25 | |
| 2017-12-31 | $73.00K 10-K · filed 2019-02-27 | |
| 2016-12-31 | $8.00K 10-K · filed 2019-02-27 | |
| 2015-12-31 | $0.00 10-K · filed 2018-03-15 | |
| 2015-06-30 | $0.00 10-K · filed 2018-03-15 |